NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球一次性血袋市場:增長、趨勢、COVID-19 影響、預測(2021-2026)

Disposable Blood Bags Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 1020426
出版日期 內容資訊 英文 115 Pages
商品交期: 2-3個工作天內
價格
全球一次性血袋市場:增長、趨勢、COVID-19 影響、預測(2021-2026) Disposable Blood Bags Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
出版日期: 2021年07月01日內容資訊: 英文 115 Pages
簡介

目前,在 COVID-19 的背景下,使用康復患者的全血或血漿進行被動免疫治療已成為一種潛在的感染治療策略。

通過恢復期血液輸注中和抗體的概念是世界各地醫院迅速採用的策略。因此,隨著使用血液和血漿的被動免疫療法的迅速普及,這些血袋越來越多地用於血漿治療過程中的血液儲存和轉移,推動了市場的增長。

全球一次性血袋市場的主要驅動力是世界各地普遍存在的創傷和嚴重傷害以及日益增加的致命事故負擔。根據世界衛生組織的數據,到 2021 年 4 月,每年有超過 130 萬人死於道路交通事故和事故。道路事故傷害是 15 至 29 歲人群的首要死因。 20 到 5000 萬人受到非致命傷害,許多人因受傷而致殘。這些嚴重的傷害通常涉及在手術過程中進行採血和輸血活動以治療致命傷害。因此,外科手術負擔的增加將提高一次性血袋的採購率,促進市場增長。

血液相關疾病和其他慢性疾病的患病率增加,再加上政府為促進獻血、採血和儲存採取的一系列舉措,預計將在預測期內推動該行業的發展。例如,世界血友病聯盟 2019 年報告稱,全球每年有超過 20,000 名血友病患者出生,其中約 7,000 人患有重病。

另外,根據加拿大政府的統計報告,截至2020年7月,加拿大老年人口為6,835,866人,佔加拿大總人口的17.5%。在加拿大,隨著時間的推移,易患心血管疾病的老年人比例不斷增加,預計這將增加手術次數,增加對一次性血袋的需求。然而,與獻血和輸血相關的高風險預計將抑制市場增長。

本報告調查了一次性血袋的全球市場,概述了市場,分析了市場增長和障礙、市場機會、COVID-19 的影響以及按袋類型、最終用戶和地區劃分的市場規模。我們提供系統信息,例如趨勢和預測、競爭形勢以及主要公司的簡介。

目錄

第 1 章介紹

第 2 章調查方法

第 3 章執行摘要

第 4 章市場動態

  • 市場概覽
  • 市場驅動力
    • 塔瑪和受傷的數量增加
    • 血液相關疾病和其他慢性疾病的負擔增加
    • 加大政府對獻血的積極性
  • 市場限制
    • 與獻血和輸血相關的高風險
  • 波特五力分析

第 5 章市場細分

  • 按袋子類型
    • 採血袋
    • 輸血袋
  • 最終用戶
    • 血庫
    • 醫院
    • 非政府組織及其他
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東和非洲
    • 南美洲

第 6 章競爭形勢

  • 公司簡介
    • AdvaCare Pharma
    • Fresenius SE &Co. KGaA
    • Genesis BPS.
    • Grifols SA
    • Haemonetics Corporation
    • HLL Lifecare Limited
    • INNVOL
    • JMS Co., Ltd.
    • Kawasumi Laboratories, Inc.
    • MacoPharma
    • Neomedic International
    • Poly Medicure Limited
    • Span Healthcare Private Limited
    • Teleflex Incorporated
    • Terumo Corporation

第 7 章市場機會和趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 72129

The Disposable Blood Bags Market is expected to register a CAGR of 4.5% during the forecast period.

In current, COVID-19 circumstances, passive immunotherapy using whole blood or plasma from recovered patients has become a potential therapeutic strategy for infections. The concept of transfusing neutralizing antibodies through convalescent blood is a rapidly adopted strategy among hospitals worldwide. Thus, owing to the rapid adoption of passive immunotherapy using blood and plasma these blood bags are increasingly being used in storing and transferring blood during plasma therapy, propelling the market growth.

The global disposable blood bag market is primarily driven by the rising burden of fatal accidents along with the wide presence of trauma and serious injuries around the world. According to the World Health Organization, in April 2021, more than 1.3 million people die every year, because of road traffic crashes and accidents. Road traffic injuries are the leading cause of death among people aged between 15 and 29 years. Between 20 and 50 million people suffer non-fatal injuries, with many incurring a disability because of their injury.​ These serious injuries are often accompanied with blood collection, and transfusion activities during the surgical procedures to treat fatal injuries. Hence, growing burden of surgical procedure will increase the procurement rate of disposable blood bags driving the market growth.

The increasing prevalence of blood-related and other chronic diseases coupled with number of government initiatives to promote blood donation, blood collection, and storage are expected to drive the industry during the forecast period. For instance, according to the World Federation Hemophilia, 2019 report, more than 20,000 people with hemophilia born worldwide each year with hemophilia of which about 7,000 are severe.

Also, as per the Government of Canada Statistics report, as of July 2020, the Canadian older population was 6,835,866, which accounted for 17.5% of the Canadian population. The proportion of seniors in Canada has been increasing over time who are more prone to cardiovascular diseases, and that is expected to fuel the number of surgical procedures, which is anticipated to increase the demand for disposable blood bags. However, high risk associated with blood donation and transfusion is anticipated to restrain market growth.

Key Market Trends

Blood Transfusion Bag is Expected to Hold the Significant Market Share

By Type of Blood, the Blood Transfusion bag is anticipated to hold a significant market share. Blood transfusion bags are used to transfer blood products into one's circulation intravenously. The blood transfusion process is used for various medical conditions to replace lost components of the blood.

The increasing burden of several chronic diseases and infectious diseases coupled with growing surgical procedures is anticipated to fuel the demand for blood transfusion bags According to the American National Red Cross, nearly around 21 million blood components are transfused each year in the United States.

Also, according to the statistics published in World Health Organization (WHO) in 2020, over 118.5 million blood donations are collected for blood transfusion to diseased patients. Globally, 40% of these are collected in high-income countries, which is home to 16% of the world's population. As per WHO, an increase of 7.8 million blood donations from voluntary unpaid donors has been reported from 2013 to 2018. This increase in awareness regarding blood donation is expected to fuel the market growth of transfusion bags. Hence, owing to the presence of aforementioned factors, the market is anticipated to have high growth during the forecast period.

North America is Expected to Retain the Largest Market Share During the Forecast Period

North America is anticipated to be one of the leading markets in the disposable blood bags market. Factors such as the increased penetration of blood tests along with a huge presence of several chronic diseases and blood-related disorders in the region are going to offer lucrative growth to the market. In addition, presence of well-established and equipped health care infrastructure, and increased blood donation activities coupled with government efforts in promoting the use of disposable blood bags to prevent infections are the factors also going to impact market growth positively.

As per the statistics published by the American National Red Cross in 2018, over 36,000 units of red blood cells are needed every day in the United States, and approximately 7,000 units of platelets and 10,000 units of plasma are needed daily in the United States. An estimated number of 6.8 million people donate blood in the United States.

On the other hand, the burden of chronic diseases is continuously increasing in this region. For instance, according to the International Agency for Research on Cancer Society, reported that in United States amounted for 2.28 million cancer in 2020, and by 2040 the burden of Cancer is estimated to reach 3.12 million. Hence, owing to the presence of all the market propelling factors in this region, North America is anticipated to offer lucrative growth in future.

Competitive Landscape

Fresenius SE & Co. KGaA, Haemonetics Corporation, MacoPharma, S.A, Teleflex Incorporated, and Terumo Corporation are some of the key players currently dominating the disposable blood bags market. The disposable blood bags market is fragmented and competitive due to the presence of a large number of players. The major players are currently aiming their attention to expand their businesses in order to strengthen their position in the market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing number of Taruma and Injuries
    • 4.2.2 Rising Burden of Blood Related and Other Chronic Disorders
    • 4.2.3 Increasing Government Initiatives for Blood Donations
  • 4.3 Market Restraints
    • 4.3.1 High Risk Associated with Blood Donation and Transfusion.
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 Type of Bag
    • 5.1.1 Blood Collection Bags
      • 5.1.1.1 Single Blood Bags
      • 5.1.1.2 Double BloodBags
      • 5.1.1.3 Triple Blood Bags
      • 5.1.1.4 Quadruple Blood Bags
    • 5.1.2 Blood Transfusion Bags
  • 5.2 End-User
    • 5.2.1 Blood Banks
    • 5.2.2 Hospitals
    • 5.2.3 Non-Government Organization and Others
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 AdvaCare Pharma
    • 6.1.2 Fresenius SE & Co. KGaA
    • 6.1.3 Genesis BPS.
    • 6.1.4 Grifols S.A
    • 6.1.5 Haemonetics Corporation
    • 6.1.6 HLL Lifecare Limited
    • 6.1.7 INNVOL
    • 6.1.8 JMS Co., Ltd.
    • 6.1.9 Kawasumi Laboratories, Inc.
    • 6.1.10 MacoPharma
    • 6.1.11 Neomedic International
    • 6.1.12 Poly Medicure Limited
    • 6.1.13 Span Healthcare Private Limited
    • 6.1.14 Teleflex Incorporated
    • 6.1.15 Terumo Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS